Caitlin John’s AstraZeneca AZN Stock Holding History

Caitlin John’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6	Closed	-$1.1K	–	945
2025 Q4	$1.1K	Hold	6	–	–	﹤0.01%	785
2025 Q3	$921	Buy	+6	New	+$908	﹤0.01%	774
2025 Q1	–	Sell	-81	Closed	-$10.6K	–	179
2024 Q4	$10.6K	Hold	81	–	–	0.01%	476
2024 Q3	$10.5K	Sell	81 -20	-20%	-$3.23K	0.01%	482
2024 Q2	$15.8K	Hold	101	–	–	0.01%	384
2024 Q1	$13.7K	Buy	101 +1	+1%	+$132	0.01%	409
2023 Q4	$13.4K	Buy	+100	New	+$13K	0.01%	392

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Caitlin John's AZN Position: Q1 2026 in Review

Caitlin John sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 6 shares — an estimated $1.1K sold.

Caitlin John first reported a position in AZN in Q4 2023 and held it in 7 quarters. The position peaked at $15.8K in Q2 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Caitlin John reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Caitlin John sold 6 AstraZeneca shares in Q1 2026, an estimated $1.1K.
Caitlin John first reported a position in AstraZeneca in Q4 2023 and held it in 7 quarters.
Caitlin John's AstraZeneca position peaked at $15.8K in Q2 2024.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.